copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Sackler family | Brothers, OxyContin, Purdue Pharma, Opioid Epidemic . . . The Sackler family formerly owned the pharmaceutical company Purdue Pharma, known for developing the highly addictive drug OxyContin They gave up control of the company in 2025 as part of a settlement for their involvement in the opioid epidemic
Dilip Shanghvi | Biography Facts | Britannica Money The son of a wholesale drug distributor, Shanghvi launched Sun Pharma soon after graduating (1982) from the University of Calcutta with a bachelor’s degree in commerce He assumed the post of managing director
Pharmaceuticals, Vaccines, Facts - Britannica Money Like most “big pharma” companies, AstraZeneca’s future depends on its ability to: Maintain a pipeline of new and improved treatments in order to manage its revenue streams as patents for its key drugs expire
Luigi Mangione | CEO Murder Suspect, Health Care Protests, Notoriety . . . Luigi Mangione is the accused killer of UnitedHealthcare CEO Brian Thompson, who was gunned down in New York City on December 4, 2024 The juxtaposition of Mangione’s youth, good looks, and privileged upbringing with what is seen by some as an act of protest against corporate greed made him a cause célèbre
The Opioid Crisis | Britannica Sackler family, American family, former owners of the pharmaceutical company Purdue Pharma Although the family is well known
Prescription Drug Costs - Encyclopedia Britannica Melissa Pistilli, “10 Top Pharma Companies by Revenue” (December 9, 2021), investingnews com Drug Discovery Development, “Pharma 50: The 50 Largest Pharmaceutical Companies in the World” (accessed March 30, 2022), drugdiscoverytrends com
McKinsey Company | Consulting Firm, Controversies, Facts - Britannica The company also worked with Purdue Pharma, the maker of OxyContin, throughout the opioid crisis Sales of the drug had been declining, so McKinsey wrote proposals with the goal to “turbocharge” its sales, ultimately making about $86 million for consulting for Purdue